Inovio Pharmaceuticals Inc. Stock Advances 10.2%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. surged 10.2% to $0.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,605.36 and Dow Jones Industrial Average falling 0.1% to 53,975.98.

The stock's rise snapped a two-day losing streak.

Inovio Pharmaceuticals Inc. closed 75.3% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $261.81, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.08% to $27.05.

Trading volume totaled 3.3 million, compared to the 50-day average of 2.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 10, 2026 16:33 ET (20:33 GMT)